Introduction
Fibrous hamartoma of infancy (FHI) is a rare, benign, fibroproliferative lesion that develops during the first 2 years of life, and up to 25% of cases are discovered 
Case Report
A 7-month-old, healthy, female baby was examined by the pediatric ophthalmologist due to a left upper eyelid lesion that appeared at birth and had been growing since then. In order to prevent amblyopia, closure of the right eye for a few hours per day was recommended, and she was referred to the oculoplastic clinic at our institution for consultation and treatment.
On examination, the left upper eyelid lesion was solid and mobile with rubber consistency ( fig. 1 a) . A mechanical ptosis was observed. The rest of the ophthalmic examination was normal. Magnetic resonance imaging of the orbits demonstrated a well-marginated, ovoid, osteolytic mass in the superior left bony orbit. The mass was isointense relative to the brain parenchyma on T1-weighted images and hyperintense to the brain parenchyma on T2-weighted images. After administration of gadolinium contrast, the mass demonstrated marked homogeneous enhancement ( fig. 2 ) . The differential diagnosis after imaging and clinical evaluation included the following etiologies: Langerhans cell histiocytosis, fibrous dysplasia, juvenile ossifying fibroma, infantile fibrosarcoma, neuroblastoma, and primitive neuroectodermal tumor. Excision of the lesion was recommended.
During surgery, a solid, infiltrative lesion, harder than normal tissue, with no obvious borders was identified ( fig. 1 b) and excised. Since the lesion was infiltrative, with no clear borders, frozen sections were performed. Fibrous tissue with bland spindle cells was histologically recognized, and the surgical margins were found to be free of lesion.
After fixation and embedding in paraffin, the hematoxylin and eosin-stained sections disclosed an 'organoid' growth pattern of fascicles of mature fibroblastic tissue, with collagen deposition, hypercellular islands of round to spindle cells set within slightly myxoid stroma, and mature adipose tissue ( fig. 3 a-c) .
The spindle cells in the hypercellular islands had bland nuclei and showed no mitotic activity. On immunostains, CD34 stained positively both for the fibroblastic fascicles and the hypercellular areas, Bcl-2 was positive only in the hypercellular areas, and the stains for β-catenin, S100, CD68, and MNF116 were negative. Based on the morphological features and the results of the immunohistochemical stains, the diagnosis of FHI was made. Today, the patient is still in follow-up in the oculoplastic clinic. The mechanical ptosis is less prominent, but there is still swelling in the nasal part of the eyelid, probably from remnants of the lesion for which future surgery is planned ( fig. 1 c) .
Discussion
In this case report, the clinical, imaging, and histopathological features of FHI located in the eyelid are described. FHI is a rare tumor and location in the eyelid is unusual.
The clinical and radiologic features of FHI are similar to other tumors. Therefore, the definite diagnosis is made only by histopathological examination. The histopathological appearance of the triphasic histologic components of mature fibroblastic tissue, immature mesenchymal tissue, and mature adipose tissue [5] is unique to this tumor, which led to the diagnosis in our case.
FHI is included in the long list of differential diagnosis for eyelid lesions in infancy [8] . This differential diagnosis includes a variety of reactive lesions and benign and malignant neoplasms: juvenile hyaline fibromatosis, lymphoma, neuroblastoma, infantile myofibroma, leiomyoma, fibrous dysplasia, nonossifying fibroma, dermoid cyst, and more. Therefore, it is important for the ophthalmologists and the pathologists to be familiar with this entity in order to avoid misdiagnosis of other fibromatosis and malignant tumor that may result in unnecessary aggressive treatment.
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